Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch

[1] Thompson DF(1993)Understanding financial conflicts of interest NEJM 329 573-576

[2] Stamatakis E(2013)Undue industry influences that distort health care, strategy, expenditure and practice: a review Eur J Clin Investig 43 469-475

[3] Weiler R(2010)Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review BMJ 340 c1344-583

[4] Ioannidis JPA(2017)Association between physicians‘ interactions with pharmaceutical companies and their clinical practices: a systematic review and meta-analysis PLoS One 12 e0175493-553

[5] Wang AT(2013)Does the pharmaceutical industry influence guidelines? Two examples from Germany Dtsch Arztebl Int 110 575-1633

[6] McCoy CP(2013)Why we can’t trust clinical guidelines BMJ 346 548-584

[7] Murad MH(2015)Guidelines international network. Principles for disclosure of interests and management of conflicts in guidelines Ann Intern Med 163 1628-842

[8] Montori VM(2012)Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress Arch Intern Med 172 d5621-451

[9] Brax H(2011)Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study BMJ 343 577-357

[10] Fadlallah R(2011)Conflicts of interest in cardiovascular clinical practice guidelines Arch Intern Med 171 e25153-428

[1] Thompson DF(1993)Understanding financial conflicts of interest NEJM 329 573-576

[2] Stamatakis E(2013)Undue industry influences that distort health care, strategy, expenditure and practice: a review Eur J Clin Investig 43 469-475

[3] Weiler R(2010)Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review BMJ 340 c1344-583

[4] Ioannidis JPA(2017)Association between physicians‘ interactions with pharmaceutical companies and their clinical practices: a systematic review and meta-analysis PLoS One 12 e0175493-553

[5] Wang AT(2013)Does the pharmaceutical industry influence guidelines? Two examples from Germany Dtsch Arztebl Int 110 575-1633

[6] McCoy CP(2013)Why we can’t trust clinical guidelines BMJ 346 548-584

[7] Murad MH(2015)Guidelines international network. Principles for disclosure of interests and management of conflicts in guidelines Ann Intern Med 163 1628-842

[8] Montori VM(2012)Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress Arch Intern Med 172 d5621-451

[9] Brax H(2011)Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study BMJ 343 577-357

[10] Fadlallah R(2011)Conflicts of interest in cardiovascular clinical practice guidelines Arch Intern Med 171 e25153-428